The_Istituto_Rizzoli-Beretta_experience_with_osteosarcoma_of_the_jaw._Twenty-eight_osteosarcomas_(OS)_of_the_jaw_were_reported._There_were_15_male_and_13_female_patients_(age_range,_9_to_68_years;_mean,_36.9_years);_57.1%_of_the_patients_were_older_than_30_years_of_age._Swelling_was_the_most_frequent_symptom;_it_was_reported_on_an_average_of_6_months_before_diagnosis._Most_of_the_tumors_of_the_maxilla_(eight_patients)_occurred_in_the_alveolar_ridge_(six_of_eight)._In_the_mandible_(20_patients),_the_body_was_the_preferred_site_(11_of_20)._Radiographically_most_of_the_lesions_were_either_lytic_and_sclerotic_or_only_lytic._Histologically,_12_cases_(42.9%)_were_osteoblastic_osteosarcoma,_ten_(35.8%)_were_chondroblastic,_four_(14.3%)_were_fibroblastic,_and_two_(7%)_were_round_cell_OS._Of_the_28_cases,_three_(10.7%)_were_low_grade,_and_25_(89.3%)_were_high_grade._Thirteen_patients_had_intralesional_surgery,_and_13_had_marginal_surgery_as_their_initial_treatment._Recurrence_was_the_rule_in_the_first_group,_and_it_was_69%_in_the_second_group._Twenty_patients_(71%)_died,_and_eight_are_alive._Of_these,_two_are_alive_with_disease._In_the_six_patients_who_are_alive_and_disease-free,_all_but_one_had_marginal_to_wide_surgical_margins_at_the_time_of_the_first_procedure_or_wide_margins_at_the_time_of_the_recurrences_along_with_chemotherapy_or_radiation_therapy._In_the_patient_in_which_the_surgical_margins_were_marginal,_the_lesion_was_small_2.5_X_2_cm._This_patient_was_alive_without_evidence_of_disease_after_9_years_of_follow-up.